Cooperative binding of effectors by an allosteric ribozyme

Area of Science:

• Molecular Biology
• Biochemistry
• RNA Catalysis

Background:

• Allosteric regulation is common in proteins, allowing for complex control of enzyme activity.
• RNA molecules, or ribozymes, can also exhibit catalytic activity and allosteric regulation.
• Understanding RNA's regulatory mechanisms is key to advancing synthetic biology and RNA-based therapeutics.

Purpose of the Study:

• To engineer a novel allosteric ribozyme responsive to two distinct effectors.
• To investigate the cooperative binding mechanism and its impact on ribozyme catalysis.
• To demonstrate a high level of structural and functional complexity in engineered RNA.

Main Methods:

• Modular rational design of a multi-module RNA construct.
• Kinetic assays to measure ribozyme self-cleavage rates.
• Structural studies to elucidate effector binding and conformational changes.

Main Results:

• Successfully created an obligate FMN- and theophylline-dependent allosteric ribozyme.
• Observed a ~300-fold rate enhancement in self-cleavage upon binding of both effectors.
• Elucidated a sequential binding mechanism where theophylline primes the ribozyme for FMN binding and activation.

Conclusions:

• Engineered RNA can exhibit sophisticated allosteric control, mirroring protein systems.
• Cooperative binding of multiple effectors enables precise regulation of ribozyme function.
• This binary RNA switch represents a significant advancement in designing complex, responsive RNA molecules.